Royal College of Surgeons, Ireland   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Dublin Ireland (1784)

Organization Overview

First Clinical Trial
2009
NCT00979745
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Beaumont Hospital, Dublin | Beaumont Hospital, Dublin, Ireland | Clinical Research Centre Royal College of Surgeons in Ireland (RCSI) | Connolly Hospital Blanchardstown | Connolly Hospital, Dublin 15, Ireland | Department of Emergency Medicine, Beaumont Hospital, Dublin | Royal College of Surgeons in Ireland | Royal College of Surgeons in Ireland - Bahrain | Royal College of Surgeons in Ireland - Medical University of Bahrain | Royal College of Surgeons, Ireland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

alpha 1-Antitrypsin Deficiency (Phase 2)

Asthma (Phase 3)

Bone Demineralization, Pathologic (Phase 4)

Cardiovascular Diseases (Phase 4)

Cellulitis (Phase 4)

Diabetes, Gestational (Phase 3)

Diabetes Mellitus (Phase 3)

Eclampsia (Phase 4)

Emergencies (Phase 4)

Fetal Growth Retardation (Phase 4)

Hemorrhage (Phase 3)

Hypotension (Phase 3)

Malaria (Phase 1)

Placenta Diseases (Phase 4)

Pre-Eclampsia (Phase 4)

Protoporphyria, Erythropoietic (Phase 3)

Wound Infection (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial APIs: 39